Skip to main content
Top
Published in: Pediatric Nephrology 8/2004

01-08-2004 | Brief Report

Challenges in the management of infantile factor H associated hemolytic uremic syndrome

Authors: Guido Filler, Seetha Radhakrishnan, Lisa Strain, Andrew Hill, Greg Knoll, Timothy H. Goodship

Published in: Pediatric Nephrology | Issue 8/2004

Login to get access

Abstract

We describe a 1-year old with four episodes of recurrent hemolytic uremic syndrome (HUS). Family history suggested an autosomal dominant mode of inheritance. Factor H concentrations in the blood were normal in the affected family members. Mutation screening in the human complement factor H gene (HF-1) revealed a novel mutation in exon 23 (c.3546_3581dup36). The HF-1 gene encodes complement factor H and the mutation leads to the insertion of 12 additional amino acids after codon 1176 in factor H. The recurrent HUS responded to plasma infusions and renal function improved from a glomerular filtration rate of 21 to 50 ml/min per 1.73 m2. The infusions of fresh-frozen plasma were necessary at once-weekly intervals at a dose of 40–45 ml/kg in order to maintain remission and resulted in significant hyperproteinemia. This was addressed by intermittent plasma exchange through an arterio-venous fistula. The prognosis and therapeutic dilemmas are discussed.
Literature
1.
go back to reference Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, Wells JG, Hemolytic Uremic Syndrome Study Collaborators (2001) The United States National Progressive Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical and epidemiologic findings. J Infect Dis 183:1063–1070 Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, Wells JG, Hemolytic Uremic Syndrome Study Collaborators (2001) The United States National Progressive Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical and epidemiologic findings. J Infect Dis 183:1063–1070
2.
go back to reference Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600 Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600
3.
go back to reference Noris M, Ruggenenti P, Perna A, Orisio S, Caprioli J, Skerka C, Vasile B, Zipfel PF, Remuzzi G (1999) Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J Am Soc Nephrol 10:281–293PubMed Noris M, Ruggenenti P, Perna A, Orisio S, Caprioli J, Skerka C, Vasile B, Zipfel PF, Remuzzi G (1999) Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J Am Soc Nephrol 10:281–293PubMed
4.
go back to reference Perkins SJ, Goodship TH (2002) Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site. J Mol Biol 316:217–224CrossRefPubMed Perkins SJ, Goodship TH (2002) Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site. J Mol Biol 316:217–224CrossRefPubMed
5.
go back to reference Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Muslumanoglu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100:12966–12971CrossRefPubMed Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Muslumanoglu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100:12966–12971CrossRefPubMed
6.
go back to reference Gianviti A, Perna A, Caringella A (1993) Plasma exchange in children with hemolytic uremic syndrome at risk of poor outcome. Am J Kidney Dis 22:264–266PubMed Gianviti A, Perna A, Caringella A (1993) Plasma exchange in children with hemolytic uremic syndrome at risk of poor outcome. Am J Kidney Dis 22:264–266PubMed
7.
go back to reference Gerber A, Kirchoff-Moradpour AH, Obieglo S, Brandis M, Kirschfink M, Zipfel P, Goodship J, Zimmerhackl L (2003) Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality. Pediatr Nephrol 18:952–955CrossRefPubMed Gerber A, Kirchoff-Moradpour AH, Obieglo S, Brandis M, Kirschfink M, Zipfel P, Goodship J, Zimmerhackl L (2003) Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality. Pediatr Nephrol 18:952–955CrossRefPubMed
8.
go back to reference Fitzpatrick M, Walters M, Trompeter R, Dillon M, Barratt M (1993) Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J Pediatr 122:532–537PubMed Fitzpatrick M, Walters M, Trompeter R, Dillon M, Barratt M (1993) Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J Pediatr 122:532–537PubMed
9.
go back to reference Loirat C, Niaudet P (2003) The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 18:1095–1101CrossRefPubMed Loirat C, Niaudet P (2003) The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 18:1095–1101CrossRefPubMed
10.
go back to reference Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985CrossRefPubMed Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985CrossRefPubMed
11.
go back to reference Ruggenenti P, Remuzzi G (1998) Pathophysiology and management of thrombotic microangiopathies. J Nephrol 11:300–310PubMed Ruggenenti P, Remuzzi G (1998) Pathophysiology and management of thrombotic microangiopathies. J Nephrol 11:300–310PubMed
12.
go back to reference Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HP, Remuzzi G, Zipfel PF (2003) Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 111:1181–1190CrossRefPubMed Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HP, Remuzzi G, Zipfel PF (2003) Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 111:1181–1190CrossRefPubMed
13.
go back to reference Pangburn MK (2002) Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. J Immunol 169:4702–4706PubMed Pangburn MK (2002) Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. J Immunol 169:4702–4706PubMed
14.
go back to reference Sanchez-Corral P, Perez-Caballero D, Huarte O, Simckes AM, Goicoechea E, Lopez-Trascasa M, Cordoba SR de (2002) Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 71:1285–1295CrossRefPubMed Sanchez-Corral P, Perez-Caballero D, Huarte O, Simckes AM, Goicoechea E, Lopez-Trascasa M, Cordoba SR de (2002) Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 71:1285–1295CrossRefPubMed
15.
go back to reference Coppo P, Bussel A, Charrier S, Adrie C, Galicier L, Boulanger E, Veyradier A, Leblanc T, Alberti C, Azoulay E, Le Gall JR, Schlemmer B (2003) High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Medicine (Baltimore) 82:27–38 Coppo P, Bussel A, Charrier S, Adrie C, Galicier L, Boulanger E, Veyradier A, Leblanc T, Alberti C, Azoulay E, Le Gall JR, Schlemmer B (2003) High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Medicine (Baltimore) 82:27–38
16.
go back to reference Eddy AA, Geary DF, Balfe JW, Clark WF, Baumal R (1989) Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy. Pediatr Nephrol 3:420–423PubMed Eddy AA, Geary DF, Balfe JW, Clark WF, Baumal R (1989) Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy. Pediatr Nephrol 3:420–423PubMed
17.
go back to reference Veyradier A, Obert B, Haddad E, Cloarec S, Nivet H, Foulard M, Lesure F, Delattre P, Lakhdari M, Meyer D, Girma JP, Loirat C (2003) Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J Pediatr 142:310–317CrossRefPubMed Veyradier A, Obert B, Haddad E, Cloarec S, Nivet H, Foulard M, Lesure F, Delattre P, Lakhdari M, Meyer D, Girma JP, Loirat C (2003) Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome. J Pediatr 142:310–317CrossRefPubMed
18.
go back to reference Madore F (2002) Plasmapheresis: technical aspects and indications. Crit Care Clin 18:375–392PubMed Madore F (2002) Plasmapheresis: technical aspects and indications. Crit Care Clin 18:375–392PubMed
19.
go back to reference Remuzzi G, Ruggenenti P, Codazzi D, Noris M, Caprioli J, Locatelli G, Gridelli B (2002) Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 359:1671–1672CrossRefPubMed Remuzzi G, Ruggenenti P, Codazzi D, Noris M, Caprioli J, Locatelli G, Gridelli B (2002) Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 359:1671–1672CrossRefPubMed
Metadata
Title
Challenges in the management of infantile factor H associated hemolytic uremic syndrome
Authors
Guido Filler
Seetha Radhakrishnan
Lisa Strain
Andrew Hill
Greg Knoll
Timothy H. Goodship
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 8/2004
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1526-9

Other articles of this Issue 8/2004

Pediatric Nephrology 8/2004 Go to the issue